More from the European comparative effectiveness research front

Apparently the German health system is to initiate a large trial to investigate the comparative effectiveness of four different treatments for men initially diagnosed with low-risk prostate cancer, starting this year. … READ MORE …

Comparative effectiveness research and localized prostate cancer

Randomized clinical trials will be carried out to determine the most effective forms of treatment for localized prostate cancer — but most of them probably aren’t going to be done in the good old USA. … READ MORE …

CEASAR study to compare effectiveness of first-line therapies for localized prostate cancer

According to a media release last Thursday and a report on Medical News Today, the Agency for Healthcare Research and Quality (AHRQ) has awarded a large grant to the Vandebilt-Ingram Cancer Center) for study of the comparative effectiveness of differing types of first-line treatment for localized prostate cancer. … READ MORE …

US research team wins contract to study comparative effectiveness of prostate cancer treatments

According to a media release issued yesterday by the University of North Carolina Lineberger Cancer Center, researchers at this institution have been  awarded the first contract we are aware of  “to conduct comparative effectiveness research comparing different management strategies for localized prostate cancer.” … READ MORE …

Comparative effectiveness and personalized medicine

The “New” Prostate Cancer InfoLink is by no means the first media outlet to have commented on the potential conflict between the idea of comparative effectiveness research (in large numbers of patients) and the the principles of personalized medicine. But we are pleased to see Dr. Francis Collins, the new director of the National Institutes of Health, weigh in in this topic. … READ MORE …